About Qureight

Our mission is to advance understanding of lung and heart disease, revolutionise clinical trials and accelerate drug development. We were founded by doctors, scientists and engineers and are based in Cambridge, UK.

Our values

Management team

Dr. Muhunthan Thillai

Chief Executive Officer & Co-founder

Muhunthan has over 20 years experience in thoracic medicine and is a board-certified Pulmonologist. He qualified as a doctor from Imperial College London and undertook specialist medical training in Oxford where he was appointed as a member of the Royal College of Physicians. He was awarded a PhD in Molecular Immunology from Imperial College London before being appointed as a consultant physician. He was previously Director of Interstitial Lung Diseases at Royal Papworth and Addenbrooke’s Hospitals Cambridge UK and is currently an Honorary Associate Professor at the University of East Anglia.

Dr. Patrick Driscoll

Chief Financial Officer & Board Director

Patrick's extensive experience in leading finance and operations includes healthcare, biotech and engineering businesses in the UK and North America. His previous roles have included responsibility for building, managing and scaling all aspects of high-tech service, manufacturing, and research businesses from start-ups to listed companies, at VetCT Specialists, CN Bio Innovations and Johnson Matthey. Patrick holds a PhD in History from the University of Cambridge and is a Fellow of the ICAEW, having trained with Deloitte.

Jessica Payne

Vice President, Business Development

Jessica brings in-depth knowledge of the clinical imaging market and over 15 years of experience in the imaging sector. With a proven track record of driving growth from start-ups to AIM-listed organisations, she is focused on developing a high-performing commercial team, growing revenue, and expanding collaborations with scientific partners and global biopharmaceutical companies. Before joining Qureight, Jessica held senior roles at IXICO plc. She earned a BSc Hons in Biology from the University of Leeds.

Dr. Simon Walsh

Chief Scientific Officer

Simon has over 19 years of experience in Radiology and is currently doing clinical work in London as a Consultant Thoracic Radiologist. He also holds a PhD in Biomedical Imaging, specialising in fibrotic lung diseases following his Fellowship at Royal Brompton and Harefield Hospital Foundation Trust. He was previously a Consultant Thoracic Radiologist at King’s Hospital Foundation Trust. He also has a background in computer science, specialising in machine learning and computer vision. His research focuses on advanced computational imaging analysis and digital biomarker discovery in diffuse lung diseases. He is the past Imaging Chair for the European Respiratory Society and in 2022 was elected to the Fleischner Society, a prestigious global group of leading Respiratory Scientists, Pulmonologists and Radiologists.

Darren Gallagher

Chief Technical Officer

Darren has a wealth of experience in the software industry with a background in big data and distributed systems. His previous roles have included Head of Engineering at Autonomy and Director of Engineering, Big Data at Hewlett Packard Enterprise. He has developed software and managed teams from large multinationals to start-ups. He is experienced in growing technology infrastructure and teams from pre-seed stage through to product launch and beyond.

Dr. Steven Bishop

Chief Data Officer

Steven has over 20 years of experience in healthcare and data science. As an undergraduate he studied Computer Science followed by Medicine at the University of Cambridge. He later went on to undertake academic and specialist training in Anaesthesia and Intensive Care Medicine, and is a Fellow of the Royal College of Anaesthetists. Steven has a longstanding passion for computational research in healthcare, with publications in the domain of critical care pathophysiology and surgical data science. Previous to Qureight, Steven was Head of Research and Strategy at CMR Surgical and Director of Clinical, Regulatory and AI at Flok Health, and brings with him a wealth of experience in building AI solutions in MedTech and HealthTech.

Debbie Henthorn

Vice President, Operations

Debbie has over 20 years' experience leading strategic operations across healthcare, academia, and biotech. She is passionate about optimising business performance and driving growth by building best-in-class operational capabilities. She has a strong track record of delivering scalable, compliance frameworks that enhance customer experience, accelerate product development, and improve service delivery. Debbie holds a Masters in Natural Sciences from the University of Cambridge.

Scientific Advisory Committee

Dr. Claus Torp Jensen

Chair of the Scientific Advisory Committee

Dr Xose-Fernandez

Principal - Open Innovation Solutions for Precision Medicine Iqvia

Professor Toby Maher

Keck School of Medicine of the University of Southern California

Dr Melissa Wickremesinghe

Imperial College London

Professor Philip Molyneaux

British Lung Foundation Professor Imperial College London

Dr Bill Bradford

Industry Expert

Dr Paul Ford

Industry Expert

Dr Pilar Rivera-Ortega

Wythenshawe Hospital

Javier Alvarez Valle

Microsoft Health Futures

Dr Kent Yip

Consultant in Clinical Oncology at West Suffolk NHS Foundation Trust

Dr John Conibear

Consultant in Clinical Oncology at Barts Health NHS Trust

Dr David Tuch

Industry Expert

Professor Tamera Corte

Director of Interstitial Lung Disease, Royal Prince Alfred Hospital NHMRC Leadership Fellow

Board of Directors

Dr. Muhunthan Thillai

Chief Executive Officer & Co-founder

Muhunthan has over 20 years experience in thoracic medicine and is a board-certified Pulmonologist. He qualified as a doctor from Imperial College London and undertook specialist medical training in Oxford where he was appointed as a member of the Royal College of Physicians. He was awarded a PhD in Molecular Immunology from Imperial College London before being appointed as a consultant physician. He was previously Director of Interstitial Lung Diseases at Royal Papworth and Addenbrooke’s Hospitals Cambridge UK and is currently an Honorary Associate Professor at the University of East Anglia.

Dr. Neil Johnston

Chair of the Board

Dr. Patrick Driscoll

Chief Financial Officer & Board Director

Patrick's extensive experience in leading finance and operations includes healthcare, biotech and engineering businesses in the UK and North America. His previous roles have included responsibility for building, managing and scaling all aspects of high-tech service, manufacturing, and research businesses from start-ups to listed companies, at VetCT Specialists, CN Bio Innovations and Johnson Matthey. Patrick holds a PhD in History from the University of Cambridge and is a Fellow of the ICAEW, having trained with Deloitte.

Dr. Debra Barker

Non Executive Director

Jennifer Winter

Non Executive Director

Investors